Von Drygalski A Giermasz A Castaman G et al. Etranacogene dezaparvovec (AMT-061 phase 2b): normalear normal FIX activity and bleed cessation in hemophilia B. Blood Adv. 2019;3(21):3241-3247.

摘要

A copy of the article’s visual abstract was erroneously published as the supplemental data file. It has been replaced by the correct supplemental data file.